XML 47 R35.htm IDEA: XBRL DOCUMENT v3.7.0.1
Share Based Compensation (Tables)
3 Months Ended
Mar. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Share-based Payment Award, Stock Options, Valuation Assumptions
The assumptions used to value SARs issued during 2017 were as follows:

 
5-year vesting SARs
7-year vesting SARs
Risk-free interest rate
2.16
%
2.24
%
Expected dividend yield
1.45
%
1.45
%
Expected common stock volatility
60.05
%
59.60
%
Expected life
6.5 years

7 years

Schedule of Share-based Compensation, Stock Options, Activity
A summary of activity in our Plans during the first three months of 2017 and 2016 is as follows:
 
For the Three Months Ended March 31,
 
2017
 
2016
 
Options/SARs
 
Weighted-Average
Exercise Price
 
Options/SARs
 
Weighted-Average
Exercise Price
Outstanding, January 1
217,857

 
$
13.56

 
244,147

 
$
14.05

Granted
87,615

 
26.01

 

 

Exercised
(2,000
)
 
6.21

 

 

Forfeited

 

 

 

Expired

 

 

 

Outstanding, March 31
303,472

 
$
17.20

 
244,147

 
$
14.05

Schedule of Share-based Compensation, Shares Authorized under Stock Option Plans, by Exercise Price Range
Other information regarding awards outstanding and exercisable at March 31, 2017 is as follows:
 
Options/SARs Outstanding
 
Options/SARs Exercisable
Range of
exercise price
# of
awards
 
WAEP
 
Wted. Avg.
Remaining
Contractual
Life (yrs)
 
Aggregate
Intrinsic
Value
(in thousands)
 
# of
awards
 
WAEP
 
Aggregate
Intrinsic
Value
(in thousands)
$2.54 - $6.00
5,000

 
$
2.54

 
6.33
 
$
95

 
5,000

 
$
2.54

 
$
95

6.01 - 10.00
5,640

 
8.91

 
1.79
 
71

 
5,640

 
8.91

 
71

10.01 - 17.50
166,717

 
12.01

 
8.07
 
1,589

 
33,343

 
12.01

 
318

17.51 - 20.00
15,100

 
17.81

 
1.28
 
57

 
15,100

 
17.81

 
57

20.01 - 25.93
111,015

 
25.99

 
8.14
 

 
23,400

 
25.93

 

 
303,472

 
17.20

 
 
 
$
1,812

 
82,483

 
16.23

 
$
541